Form 4 for SANA Sana Biotechnology, Inc.
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001562180-21-005810 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-03 | 2021-09-01 | SANA | Hordo Christian | EVP, Chief Business Off | S - Sale+OE | $25.01 | -4,136 | 970.8K | -0.4% | -$103.4K |
| D | 2021-09-03 | 2021-09-01 | SANA | Hordo Christian | EVP, Chief Business Off | M - OptEx | $1.48 | +1,134 | 974.9K | +0.1% | +$1,678 |
| D | 2021-09-03 | 2021-09-01 | SANA | Hordo Christian | EVP, Chief Business Off | M - OptEx | $0.00 | -1,134 | 135.3K | -0.8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-01 | S | D | 1,134 | $25.00 | 973,800 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. |
| 2 | Common | Common Stock | 2021-09-01 | S | D | 3,002 | $25.01 | 970,798 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.03, inclusive. |
| 3 | Common | Common Stock | 2021-09-01 | M | A | 1,134 | $1.48 | 974,934 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-09-01 | M | D | 1,134 | $0.00 | 135,266 | D | $1.48 · — to 2030-01-26 | 1,134 Common Stock | (F4) This option began vesting on February 14, 2020, with 25% of the underlying shares becoming vested and exercisable on February 14, 2021 and the remainder of the underlying shares vesting at a rate of 1/36th per month thereafter. |